{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T19:15:41Z","timestamp":1754162141690,"version":"3.41.2"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest New Drugs"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1023\/a:1010672618269","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T22:31:49Z","timestamp":1040596309000},"page":"233-237","source":"Crossref","is-referenced-by-count":4,"title":["N-Methylformamide in Advanced Squamous Cancer of the Uterine Cervix: An Eastern Cooperative Oncology Group Phase II Trial"],"prefix":"10.1007","volume":"19","author":[{"given":"Lakshmi","family":"Rajdev","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-Fan","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Wadler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edie","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. Benham","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglass","family":"Tormey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Skeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H.","family":"Wiernik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"338102_CR1","volume-title":"Cancer Epidemiology and Prevention","year":"1996","unstructured":"Schottenfeld H, Fraumeni JF, Jr. eds: Cancer Epidemiology and Prevention. 2nd ed. New York: Oxford Press, 1996.","edition":"2nd ed."},{"key":"338102_CR2","first-page":"5","volume":"47","author":"SL Parker","year":"1997","unstructured":"Parker SL, Tong T, Bolden S, Wingo PA: Cancer Statistics. 1997. Ca Cancer J Clin 47: 5\u201327, 1997","journal-title":"Ca Cancer J Clin"},{"key":"338102_CR3","first-page":"1433","volume-title":"Cancer: Principles and Practice of Oncology","author":"PJ Eifel","year":"1997","unstructured":"Eifel PJ, Berek JS, Thigpen JT: Cancer of the Cervix, Vagina, and Vulva. In DeVita VT, Hellman S, Rosenberg SA (eds). Cancer: Principles and Practice of Oncology, 5th ed. Philadelphia, PA: Lippincott-Raven, 1997, pp 1433\u20131478","edition":"5th ed."},{"issue":"2","key":"338102_CR4","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/00000421-199404000-00007","volume":"17","author":"RF Asbury","year":"1994","unstructured":"Asbury RF, Blessing TA, Soper JT: A GOG phase II study of Amonafide (NSC# 308847) in squamous cell carcinoma of the cervix. Am J Clin Oncol 17(2): 125\u2013128, 1994","journal-title":"Am J Clin Oncol"},{"key":"338102_CR5","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1006\/gyno.1993.1003","volume":"48","author":"HO Smith","year":"1993","unstructured":"Smith HO, Stringer CA, Kavanagh JJ, Gershenson DM, Edwards CL, Wharton JT: Treatment of advanced and recurrent squamous cell carcinoma of the uterine cervix with mitomycin-c, bleomycin and cisplatinum chemotherapy. Gynecol Oncol 48: 11\u201315, 1993","journal-title":"Gynecol Oncol"},{"key":"338102_CR6","first-page":"1297","volume":"46","author":"RF Cordeiro","year":"1986","unstructured":"Cordeiro RF, Savarese M: Role of glutathizone depletion in the mechanism of action of N-Methylformamide and N_cimethylformaldamide in cultured human colon carcinoma cell lines. Cancer Res 46: 1297\u20131305, 1986","journal-title":"Cancer Res"},{"key":"338102_CR7","first-page":"573","volume-title":"The Retinoids: Biology, Chemistry and Medicine","author":"RC Moon","year":"1994","unstructured":"Moon RC, Mehta RG, Rao KUN: Retinoids and cancer in experimental animals. In Sporn MB, Roberts AM, Goodman DS, (eds), The Retinoids: Biology, Chemistry and Medicine, 2nd edn. New York: Raven Press, 1994, pp 573-595","edition":"2nd edn."},{"key":"338102_CR8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.3181\/00379727-84-20590","volume":"84","author":"CA Clarke","year":"1953","unstructured":"Clarke CA, Philips FS, Sternberg SS: Effects of NMethylformamide and related compounds in sarcoma 180.Proc Soc Exp Bio Med 84: 203\u2013207, 1953","journal-title":"Proc Soc Exp Bio Med"},{"key":"338102_CR9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/BF01494291","volume":"32","author":"H Braunsteiner","year":"1954","unstructured":"Braunsteiner H: Antileukamische Wirkung von N-Methylformamide. Klin Wochenschrift 32: 611\u2013612, 1954","journal-title":"Klin Wochenschrift"},{"key":"338102_CR10","first-page":"413","volume":"18","author":"M Potter","year":"1957","unstructured":"Potter M, Law WL: Studies of a plasma-cell neoplasm of the mouse. I. Characterization of neoplasm 70429, including its sensitivity to various antimetabolites with the rapid development of resistance to azaserine, DON, and NMF. JNCI 18: 413\u2013441, 1957","journal-title":"JNCI"},{"key":"338102_CR11","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1002\/1097-0142(19841201)54:2+<2766::AID-CNCR2820541424>3.0.CO;2-N","volume":"54","author":"PA Marks","year":"1984","unstructured":"Marks PA, Rifkind RA: Differentiation modifiers. Cancer 54: 2766\u20132769, 1984","journal-title":"Cancer"},{"key":"338102_CR12","doi-asserted-by":"crossref","first-page":"10251","DOI":"10.1073\/pnas.91.22.10251","volume":"91","author":"P Marks","year":"1994","unstructured":"Marks P, Richon VM, Kiyokawa H, Rifkind RA: Inducing differentiation of transformed cells with hybrid polar compounds: A cell cycle dependent process. Proc Natl Acad Sci 91: 10251\u201310254, 1994","journal-title":"Proc Natl Acad Sci"},{"key":"338102_CR13","doi-asserted-by":"crossref","first-page":"5705","DOI":"10.1073\/pnas.93.12.5705","volume":"93","author":"VM Richon","year":"1996","unstructured":"Richon VM, Webb Y, Merger R, Sheppard T, Jursic B, Ngo L, Civoli F, Breslow R, Rifkind RA, Marks P: Second generation hybrid polar compounds are potent inducers of transformed cell differentiation. Proc Natl Acad Sci 93: 5705\u20135708, 1996","journal-title":"Proc Natl Acad Sci"},{"key":"338102_CR14","volume-title":"Guidelines for Reporting of Adverse Drug Reactions","author":"National Cancer Institute","year":"1988","unstructured":"National Cancer Institute: Guidelines for Reporting of Adverse Drug Reactions. Bethesda, MD, Division of Cancer Treatment, National Cancer Institute, 1988."},{"key":"338102_CR15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","volume":"5","author":"MM Oken","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, Mc-Fadden ET, Carbone PP: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649\u2013655, 1982","journal-title":"Am J Clin Oncol"},{"key":"338102_CR16","unstructured":"Phase I minutes:Division of Cancer Treatment, National Cancer Institute, Bethesda, MD, NCI, June 1983"},{"key":"338102_CR17","first-page":"38","volume":"4","author":"MC Wienmann","year":"1985","unstructured":"Wienmann MC, Cummings FJ: Phase I clinical and pharmacological trial of oral NMF. Proc AM Soc Clin Oncol 4: 38, 1985 (abstr)","journal-title":"Proc AM Soc Clin Oncol"},{"key":"338102_CR18","first-page":"489","volume":"69","author":"DS Ettinger","year":"1985","unstructured":"Ettinger DS, Orr DW, Rice AP: Phase I study of NMF in patients with advanced cancer. Cancer Treat Rep 69: 489-493, 1985","journal-title":"Cancer Treat Rep"},{"key":"338102_CR19","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1200\/JCO.1985.3.6.853","volume":"3","author":"PJ O'Dwyer","year":"1985","unstructured":"O'Dwyer PJ, Donehower M, Sigman LM: Phase I trial of NMF. J Clin Oncol 3: 853\u2013857, 1985","journal-title":"J Clin Oncol"},{"key":"338102_CR20","first-page":"607","volume":"68","author":"JG McVie","year":"1984","unstructured":"McVie JG, ten Bokkel Huinink WW, Simonetti G et al: Phase I trial of NMF. Cancer Treat Rep 68: 607\u2013610, 1984","journal-title":"Cancer Treat Rep"},{"key":"338102_CR21","unstructured":"Verweij J, Klijn JGM, Planting ASTh, et al: NMF in metastatic colorectal cancer: a phase II study. Fifth NCI-EORTC Symposium on New Drugs in Cancer Therapy, October 22-24, 1986 (abstr 2.12)"},{"key":"338102_CR22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/jnci\/86.7.539","volume":"86","author":"F. Meyskens Jr","year":"1994","unstructured":"Meyskens Fl Jr, Surwit E, Moon TE et al: Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 86: 539, 1994","journal-title":"J Natl Cancer Inst"},{"key":"338102_CR23","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1006\/gyno.1998.5204","volume":"71","author":"GR Weiss","year":"1998","unstructured":"Weiss GR, Liu PY, Lippman SM et al: 13-cis-Retinoic Acid or All-trans-Retinoic Acid plus Interferon alpha in Recurrent Cervical Cancer: A Southwest Oncology Group Phase II Randomized Trial. Gyn Onc 71: 386\u2013390, 1998","journal-title":"Gyn Onc"}],"container-title":["Investigational New Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010672618269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1010672618269\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1010672618269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T19:57:44Z","timestamp":1753819064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1010672618269"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["338102"],"URL":"https:\/\/doi.org\/10.1023\/a:1010672618269","relation":{},"ISSN":["0167-6997","1573-0646"],"issn-type":[{"type":"print","value":"0167-6997"},{"type":"electronic","value":"1573-0646"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}